Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - SHORT-TERM INVESTMENTS
Short-term Investments RARE - Ultragenyx Pharmaceutical Inc.
364 M
LAST VALUE
-8.32%
2 YEAR CAGR
0.98%
5 YEAR CAGR
22.98%
10 YEAR CAGR